FDA NDC Directory · JSON-LD · Markdown

Lamivudine and Zidovudine

NDC 76282-115 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerExelan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203259
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsLAMIVUDINE (150 mg/1)
ZIDOVUDINE (300 mg/1)
Marketing started20150429
Package count2

External sources

Source: openFDA. Public-domain (CC0).